Veradigm Inc. (MDRX) Form 10-K — May 26, 2026
Veradigm Inc. filed its Annual Report on Form 10-K for the fiscal years ended December 31, 2023 and December 31, 2024, on May 26, 2026. The filing includes standard certifications from Principal Executive Officer Donald Trigg and Interim CFO Leland Westerfield confirming the accuracy of the financial statements and internal controls. The exhibits disclose the terms of Veradigm’s poison pill (Stockholder Rights Agreement), which expires on December 31, 2026, and includes a flip-in provision triggered if any person acquires 20% or more of the company’s shares without board approval.
Key figures
- Poison pill expiration
- December 31, 2026
- Authorized common shares
- 349,000,000
- Poison pill exercise price
- $32.00
- Authorized preferred shares
- 1,000,000
- Poison pill trigger threshold
- 20%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.